ロード中...
FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
Colorectal cancer (CRC), the second leading cause of cancer-related deaths in the US, has been treated with targeted therapies. However, the mechanisms of differential responses and resistance of CRCs to targeted therapies are not well understood. In this study, we found that genetic alterations of...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226932/ https://ncbi.nlm.nih.gov/pubmed/27399335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.247 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|